A subpopulation of CSCs characterized by high levels of CD44v3 and aldehyde dehydrogenase-1 (ALDH1) expression has been identified in HNSCC-derived HSC-3 cells and HNSCC patient samples. The gene discussed is ALDH1A1; the disease is head and neck squamous cell carcinoma.